Toll-like receptor 2 – Filamin A complex (TLR2-FLNA)

The Toll-like receptor 2 – Filamin A (TLR2-FLNA) complex is a functional signaling unit where the actin-binding scaffold protein Filamin A facilitates the activation of the innate immune receptor TLR2. TLR2 is a pattern recognition receptor essential for detecting pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), triggering the innate immune response (Shifrin et al., 2009). Filamin A acts as a critical link, anchoring TLR2 to the actin cytoskeleton and recruiting downstream adapters like MyD88 to initiate NF-κB activation and pro-inflammatory cytokine production (Wang et al., 2008). In pathological states, particularly neurodegenerative diseases like Alzheimer's and chronic pain conditions, this complex is overactive, leading to persistent microglial activation and neurotoxicity (Burns & Wang, 2017). Therapeutic strategies targeting this complex, such as small molecules like Simufilam (PTI-125) or (+)-Naloxone, aim to stabilize Filamin A in a non-pathological conformation. This stabilization disrupts the recruitment of Filamin A to TLR2, thereby suppressing aberrant inflammatory signaling without completely abolishing immune function. This approach offers a potential method to modulate neuroinflammation in diseases characterized by chronic innate immune activation. The complex represents a novel target for precision medicine, with biomarkers like SavaDx being developed to monitor Filamin A conformational changes.

Other names

TLR2-FLNA signaling complexFilamin A-TLR2 complexTLR2/FLNA complex

Stabilization of the native conformation of Filamin A to prevent its pathological association with Toll-like receptor 2, thereby inhibiting MyD88 recruitment and downstream pro-inflammatory signaling.